Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Santoni-Rugiu

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Acta Oncologica (Stockholm, Sweden)|May 21, 2026
Survival and relapse of Danish patients with thymic epithelial tumorsTine Østergaard, Caroline Van Alstine Bjerke, Eric Santoni-Rugiu, et al.
International Journal of Molecular Sciences|November 13, 2021
The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic TargetPınar Çakılkaya, Rikke Raagaard Sørensen, Henrik Jessen Jürgensen, et al.
The American Journal of Pathology|October 9, 2002
Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1Hanne Cathrine Bisgaard, Uffe Holmskov, Eric Santoni-Rugiu, et al.
Gastroenterology|September 20, 2017
CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular CarcinomaLars H Engelholm, Anjum Riaz, Denise Serra, et al.
International Journal of Molecular Sciences|January 10, 2026
Improvement of Diagnostics in NSCLC Patients with <i>MET</i> Exon 14 Mutations Using Complementary DNA/RNA-NGS and Identification of Two Novel Exonic Splicing MutationsEdyta Maria Urbanska, Thomas Koed Doktor, Linea Cecilie Melchior, et al.
Cancer Gene Therapy|September 19, 2024
BAG2, MAD2L1, and MDK are cancer-driver genes and candidate targets for novel therapies in malignant pleural mesotheliomaLuisa Bisceglia, Federica Morani, Lara Guerrieri, et al.
Plos Genetics|November 9, 2013
Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female miceGustavo Stadthagen, Disa Tehler, Nina Molin Høyland-Kroghsbo, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 15, 2026
Bedside Post-Mortem Tissue Biopsy: Diagnostic Approach in ICU Patients?Birgitte Grønkær Toft, Lise Mette Rahbek Gjerdrum, Ulf Gøttrup Pedersen, et al.
BMC Research Notes|November 28, 2013
Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case reportHenrik H Rossing, Morten Grauslund, Edyta M Urbanska, et al.
Plos One|June 28, 2012
No effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancerElisabeth P Cramer, Andreas Glenthøj, Mattias Häger, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Acta Oncologica (Stockholm, Sweden)|May 21, 2026
Survival and relapse of Danish patients with thymic epithelial tumorsTine Østergaard, Caroline Van Alstine Bjerke, Eric Santoni-Rugiu, et al.
International Journal of Molecular Sciences|November 13, 2021
The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic TargetPınar Çakılkaya, Rikke Raagaard Sørensen, Henrik Jessen Jürgensen, et al.
The American Journal of Pathology|October 9, 2002
Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1Hanne Cathrine Bisgaard, Uffe Holmskov, Eric Santoni-Rugiu, et al.
Gastroenterology|September 20, 2017
CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular CarcinomaLars H Engelholm, Anjum Riaz, Denise Serra, et al.
International Journal of Molecular Sciences|January 10, 2026
Improvement of Diagnostics in NSCLC Patients with <i>MET</i> Exon 14 Mutations Using Complementary DNA/RNA-NGS and Identification of Two Novel Exonic Splicing MutationsEdyta Maria Urbanska, Thomas Koed Doktor, Linea Cecilie Melchior, et al.
Cancer Gene Therapy|September 19, 2024
BAG2, MAD2L1, and MDK are cancer-driver genes and candidate targets for novel therapies in malignant pleural mesotheliomaLuisa Bisceglia, Federica Morani, Lara Guerrieri, et al.
Plos Genetics|November 9, 2013
Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female miceGustavo Stadthagen, Disa Tehler, Nina Molin Høyland-Kroghsbo, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 15, 2026
Bedside Post-Mortem Tissue Biopsy: Diagnostic Approach in ICU Patients?Birgitte Grønkær Toft, Lise Mette Rahbek Gjerdrum, Ulf Gøttrup Pedersen, et al.
BMC Research Notes|November 28, 2013
Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case reportHenrik H Rossing, Morten Grauslund, Edyta M Urbanska, et al.
Plos One|June 28, 2012
No effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancerElisabeth P Cramer, Andreas Glenthøj, Mattias Häger, et al.
Pageof 10